Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Acosta

Showing results (161-170 of 338) with videos related to

Pageof 34
Sort By:
British Journal of Clinical Pharmacology|December 16, 2025
Off-label dosing of long-acting injectable cabotegravir and rilpivirine during pregnancy: A case study with therapeutic drug monitoringNatella Rakhmanina, Justin Unternaher, Tierra Williams, et al.
Journal of Fungi (Basel, Switzerland)|December 22, 2022
Alumina as an Antifungal Agent for <i>Pinus elliottii</i> WoodAndrey P Acosta, Ezequiel Gallio, Nidria Cruz, et al.
AIDS (London, England)|January 12, 2001
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patientsX J Zhou, D V Havlir, D D Richman, et al.
HIV Clinical Trials|December 14, 2001
Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant womenE P Acosta, C Zorrilla, R Van Dyke, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistanceHulin Wu, Yangxin Huang, Edward P Acosta, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2012
Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility dataEdward P Acosta, Kay L Limoli, Lan Trinh, et al.
Toxicology Letters|January 4, 2001
Acute and oral subchronic toxicity of D-003 in ratsR Gámez, R Mas, M Noa, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 12, 2020
Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapyJennifer S Guimbellot, Kevin J Ryan, Justin D Anderson, et al.
AIDS (London, England)|July 14, 2018
HIV RNA persists in rectal tissue despite rapid plasma virologic suppression with dolutegravir-based therapyCecile D Lahiri, Nakita L Brown, Kevin J Ryan, et al.
Journal of Clinical Pharmacology|February 12, 2010
The effect of acid reduction with a proton pump inhibitor on the pharmacokinetics of lopinavir or ritonavir in HIV-infected patients on lopinavir/ritonavir-based therapyEdgar T Overton, Jean M Tschampa, Michael Klebert, et al.
Pageof 34

Showing results (161-170 of 338) with videos related to

Sort By:
Pageof 34
British Journal of Clinical Pharmacology|December 16, 2025
Off-label dosing of long-acting injectable cabotegravir and rilpivirine during pregnancy: A case study with therapeutic drug monitoringNatella Rakhmanina, Justin Unternaher, Tierra Williams, et al.
Journal of Fungi (Basel, Switzerland)|December 22, 2022
Alumina as an Antifungal Agent for <i>Pinus elliottii</i> WoodAndrey P Acosta, Ezequiel Gallio, Nidria Cruz, et al.
AIDS (London, England)|January 12, 2001
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patientsX J Zhou, D V Havlir, D D Richman, et al.
HIV Clinical Trials|December 14, 2001
Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant womenE P Acosta, C Zorrilla, R Van Dyke, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistanceHulin Wu, Yangxin Huang, Edward P Acosta, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2012
Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility dataEdward P Acosta, Kay L Limoli, Lan Trinh, et al.
Toxicology Letters|January 4, 2001
Acute and oral subchronic toxicity of D-003 in ratsR Gámez, R Mas, M Noa, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 12, 2020
Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapyJennifer S Guimbellot, Kevin J Ryan, Justin D Anderson, et al.
AIDS (London, England)|July 14, 2018
HIV RNA persists in rectal tissue despite rapid plasma virologic suppression with dolutegravir-based therapyCecile D Lahiri, Nakita L Brown, Kevin J Ryan, et al.
Journal of Clinical Pharmacology|February 12, 2010
The effect of acid reduction with a proton pump inhibitor on the pharmacokinetics of lopinavir or ritonavir in HIV-infected patients on lopinavir/ritonavir-based therapyEdgar T Overton, Jean M Tschampa, Michael Klebert, et al.
Pageof 34